Madeleine Arndt

About

Madeleine Arndt is a leading urologic surgeon and researcher whose work focuses on improving outcomes for men undergoing robot-assisted radical prostatectomy (RARP) and pelvic lymph node dissection (PLND). Her major contribution is the development and validation of bilateral peritoneal flaps (PIF) to reduce the incidence and complications of lymphoceles—a common and often debilitating post-surgical complication. As the lead author of the landmark prospective, randomized multicenter ProLy trial (2022, 34 citations), she demonstrated that this simple surgical technique significantly lowers lymphocele rates, a finding that has already influenced clinical practice. Her subsequent research (2023, 8 citations) further identified high BMI and prolonged surgical time as key risk factors for lymphocele formation, providing actionable insights for patient counseling and operative planning. With her work cited in top urology journals and shaping guidelines, Arndt’s contributions are helping to standardize safer, more effective surgical approaches. Her dedication to rigorous, patient-centered research makes her a rising authority in urologic oncology.

Research Focus

Key Achievements

Top Papers

1. 1
   Bilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles after Robotic Radical Prostatectomy with Pelvic Lymph Node Dissection—Results of the Prospective Randomized Multicenter Trial ProLy

   34 citations · 2022
2. 2
   High BMI and Surgical Time Are Significant Predictors of Lymphocele after Robot-Assisted Radical Prostatectomy

   8 citations · 2023
3. 3
   Bilateral Peritoneal Flaps Reduce Incidence and Complications of Lymphoceles After Robotic Radical Prostatectomy With Pelvic Lymph Node Dissection—Results of the Prospective Randomized Multicenter Trial ProLy. Reply.

   2 citations · 2022

Key Collaborators

Contact & Links